lexapro has been researched along with simvastatin in 1 studies
Studies (lexapro) | Trials (lexapro) | Recent Studies (post-2010) (lexapro) | Studies (simvastatin) | Trials (simvastatin) | Recent Studies (post-2010) (simvastatin) |
---|---|---|---|---|---|
17 | 0 | 12 | 8,442 | 1,730 | 3,630 |
Protein | Taxonomy | lexapro (IC50) | simvastatin (IC50) |
---|---|---|---|
photoreceptor-specific nuclear receptor | Homo sapiens (human) | 1.164 | |
transactivating tegument protein VP16 [Human herpesvirus 1] | Human alphaherpesvirus 1 (Herpes simplex virus type 1) | 4.426 | |
Bile salt export pump | Homo sapiens (human) | 10 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.7843 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 9.5 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 0.0034 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0034 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0111 | |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 0.049 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 6.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
1 other study(ies) available for lexapro and simvastatin
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |